Mammography firms move toward 3D digital breast tomosynthesis

Article

GE, Hologic will show full-field works in progressWith its acquisition of Instrumentarium completed on Oct. 9, GE Medical Systems (South Hall 4100) is poised to begin delivering advanced mammography applications, including

GE, Hologic will show full-field works in progress

With its acquisition of Instrumentarium completed on Oct. 9, GE Medical Systems (South Hall 4100) is poised to begin delivering advanced mammography applications, including tomosynthesis.

"With our in-house expertise and the patent, we are comfortable that we will be developing our tomosynthesis program quickly," said Laura Bakosh, general manager of women's healthcare for GE in the Americas.

The tuned aperture CT (TACT) 3D product developed by Instrumentarium is a stepping stone to full-field breast tomosynthesis. TACT obtains images from several angles as the x-ray source moves along the top of the breast. It uses a reference point located above the breast to calculate imaging geometry. GE's full-field digital tomosynthesis captures images from 11 positions as the x-ray tube navigates across a 50º arc. The technique reconstructs the images as 1-mm-thick planar scans with a pixel resolution of 100 mm throughout the breast.

A workstation optimized to display the results of tomosynthesis will accompany TACT 3D in the GE booth at the RSNA meeting.

Hologic (South Hall 2709) is also in the race to develop breast tomosynthesis. At the RSNA meeting, Hologic will demonstrate a work-in-progress tomosynthesis hardware and software package that can be added to the Selenia full-field digital mammography system. The package, slated for delivery around the world next year, acquires a full volume of data without increasing the x-ray dose beyond conventional screen-film or digital mammography levels.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.